Literature DB >> 1894383

Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers.

J X Bao1, J D Clements.   

Abstract

Prior immunologic experience with homologous and heterologous serotype Salmonella strains potentiated the subsequent antibody response when the same strains were used as vaccine carriers of foreign antigens. This potentiation was positively correlated with the appearance of antibody directed against the lipopolysaccharide of the carrier strain. Both serum and mucosal antibody responses against the foreign antigen increased over time. Antibody responses in sera of animals primed with either the homologous or heterologous serotype strain were not statistically significantly different, while animals primed with the homologous serotype strain developed significantly better mucosal antibody responses against the foreign antigen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894383      PMCID: PMC258962          DOI: 10.1128/iai.59.10.3841-3845.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus.

Authors:  T J Stabel; J E Mayfield; L B Tabatabai; M J Wannemuehler
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

2.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

3.  Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).

Authors:  E C Tramont; R Chung; S Berman; D Keren; C Kapfer; S B Formal
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

4.  Genetically conferred defect in anti-Salmonella antibody formation renders CBA/N mice innately susceptible to Salmonella typhimurium infection.

Authors:  A D O'Brien; I Scher; E S Metcalf
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

6.  A controlled field trial of liver oral typhoid vaccine Ty21a.

Authors:  M H Wahdan; C Serie; R Germanier; A Lackany; Y Cerisier; N Guerin; S Sallam; P Geoffroy; A S el Tantawi; P Guesry
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

7.  Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.

Authors:  R H Gilman; R B Hornick; W E Woodard; H L DuPont; M J Snyder; M M Levine; J P Libonati
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

8.  Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves.

Authors:  B P Smith; M Reina-Guerra; S K Hoiseth; B A Stocker; F Habasha; E Johnson; F Merritt
Journal:  Am J Vet Res       Date:  1984-01       Impact factor: 1.156

9.  Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium.

Authors:  J C Lee; C W Gibson; T K Eisenstein
Journal:  Cell Immunol       Date:  1985-03       Impact factor: 4.868

10.  Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves.

Authors:  B A Stocker; S K Hoiseth; B P Smith
Journal:  Dev Biol Stand       Date:  1983
View more
  18 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 2.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

3.  Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors.

Authors:  J J Kohler; L Pathangey; A Hasona; A Progulske-Fox; T A Brown
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned protein.

Authors:  C Jespersgaard; P Zhang; G Hajishengallis; M W Russell; S M Michalek
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin.

Authors:  J J Kohler; L B Pathangey; S R Gillespie; T A Brown
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.

Authors:  M Roberts; A Bacon; J Li; S Chatfield
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter.

Authors:  Huaiqing Chen; Dieter M Schifferli
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.

Authors:  Christofer J Vindurampulle; Stephen R Attridge
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen.

Authors:  M Gheorghiu; M R Lagranderie; B M Gicquel; C D Leclerc
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.

Authors:  J A Chabalgoity; B Villareal-Ramos; C M Khan; S N Chatfield; R D de Hormaeche; C E Hormaeche
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.